カテゴリ： 世界, 医療/バイオ, Market Monitor Global

レゴラフェニブ錠のグローバル市場展望 2023年-2029年：錠剤、分散錠、徐放錠

■ 英語タイトル：Regorafenib Tablets Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート（データ管理コード：MMG23DC14455）■ 発行会社/調査会社：Market Monitor Global
■ 商品コード：MMG23DC14455
■ 発行日：2023年12月
■ 調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野：医薬品
■ ページ数：74
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[レゴラフェニブ錠のグローバル市場展望 2023年-2029年：錠剤、分散錠、徐放錠]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査レポートは次の情報を含め、世界のレゴラフェニブ錠市場規模と予測を収録しています。・世界のレゴラフェニブ錠市場：売上、2018年-2023年、2024年-2029年
・世界のレゴラフェニブ錠市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のレゴラフェニブ錠市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「錠剤」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

レゴラフェニブ錠のグローバル主要企業は、Bayer、 Natco、 Kimia Pharmaceutical、 Beacon Pharmaceuticals、 Drug Internationalなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、レゴラフェニブ錠のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界のレゴラフェニブ錠市場：タイプ別、2018年-2023年、2024年-2029年
世界のレゴラフェニブ錠市場：タイプ別市場シェア、2022年
・錠剤、分散錠、徐放錠

世界のレゴラフェニブ錠市場：用途別、2018年-2023年、2024年-2029年
世界のレゴラフェニブ錠市場：用途別市場シェア、2022年
・病院、診療所、その他

世界のレゴラフェニブ錠市場：地域・国別、2018年-2023年、2024年-2029年
世界のレゴラフェニブ錠市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業におけるレゴラフェニブ錠のグローバル売上、2018年-2023年
・主要企業におけるレゴラフェニブ錠のグローバル売上シェア、2022年
・主要企業におけるレゴラフェニブ錠のグローバル販売量、2018年-2023年
・主要企業におけるレゴラフェニブ錠のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Bayer、 Natco、 Kimia Pharmaceutical、 Beacon Pharmaceuticals、 Drug International

*************************************************************

・調査・分析レポートの概要
レゴラフェニブ錠市場の定義
市場セグメント
世界のレゴラフェニブ錠市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のレゴラフェニブ錠市場規模
世界のレゴラフェニブ錠市場規模：2022年 VS 2029年
世界のレゴラフェニブ錠市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのレゴラフェニブ錠の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のレゴラフェニブ錠製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：錠剤、分散錠、徐放錠
レゴラフェニブ錠のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、診療所、その他
レゴラフェニブ錠の用途別グローバル売上・予測

・地域別市場分析
地域別レゴラフェニブ錠市場規模 2022年と2029年
地域別レゴラフェニブ錠売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Bayer、 Natco、 Kimia Pharmaceutical、 Beacon Pharmaceuticals、 Drug International
...

This research report provides a comprehensive analysis of the Regorafenib Tablets market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Regorafenib Tablets market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Regorafenib Tablets, challenges faced by the industry, and potential opportunities for market players.
The global Regorafenib Tablets market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Regorafenib Tablets market presents opportunities for various stakeholders, including Hospitals, Clinics. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Regorafenib Tablets market. Additionally, the growing consumer demand present avenues for market expansion.
The global Regorafenib Tablets market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period.
Key Features:
The research report on the Regorafenib Tablets market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Regorafenib Tablets market.
Market Overview: The report provides a comprehensive overview of the Regorafenib Tablets market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Tablets, Dispersible Tablets), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Regorafenib Tablets market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Regorafenib Tablets market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Regorafenib Tablets market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Regorafenib Tablets market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Regorafenib Tablets market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Regorafenib Tablets market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Regorafenib Tablets, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Regorafenib Tablets market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Regorafenib Tablets market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Tablets
Dispersible Tablets
Extended-Release Tablets
Market segment by Application
Hospitals
Clinics
Others
Global Regorafenib Tablets Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Bayer
Natco
Kimia Pharmaceutical
Beacon Pharmaceuticals
Drug International
Outline of Major Chapters:
Chapter 1: Introduces the definition of Regorafenib Tablets, market overview.
Chapter 2: Global Regorafenib Tablets market size in revenue and volume.
Chapter 3: Detailed analysis of Regorafenib Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Regorafenib Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Regorafenib Tablets capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Introduction to Research & Analysis Reports
1.1 Regorafenib Tablets Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Regorafenib Tablets Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Regorafenib Tablets Overall Market Size
2.1 Global Regorafenib Tablets Market Size: 2022 VS 2029
2.2 Global Regorafenib Tablets Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Regorafenib Tablets Sales: 2018-2029
3 Company Landscape
3.1 Top Regorafenib Tablets Players in Global Market
3.2 Top Global Regorafenib Tablets Companies Ranked by Revenue
3.3 Global Regorafenib Tablets Revenue by Companies
3.4 Global Regorafenib Tablets Sales by Companies
3.5 Global Regorafenib Tablets Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Regorafenib Tablets Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Regorafenib Tablets Product Type
3.8 Tier 1, Tier 2 and Tier 3 Regorafenib Tablets Players in Global Market
3.8.1 List of Global Tier 1 Regorafenib Tablets Companies
3.8.2 List of Global Tier 2 and Tier 3 Regorafenib Tablets Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Regorafenib Tablets Market Size Markets, 2022 & 2029
4.1.2 Tablets
4.1.3 Dispersible Tablets
4.1.4 Extended-Release Tablets
4.2 By Type – Global Regorafenib Tablets Revenue & Forecasts
4.2.1 By Type – Global Regorafenib Tablets Revenue, 2018-2023
4.2.2 By Type – Global Regorafenib Tablets Revenue, 2024-2029
4.2.3 By Type – Global Regorafenib Tablets Revenue Market Share, 2018-2029
4.3 By Type – Global Regorafenib Tablets Sales & Forecasts
4.3.1 By Type – Global Regorafenib Tablets Sales, 2018-2023
4.3.2 By Type – Global Regorafenib Tablets Sales, 2024-2029
4.3.3 By Type – Global Regorafenib Tablets Sales Market Share, 2018-2029
4.4 By Type – Global Regorafenib Tablets Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Regorafenib Tablets Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application – Global Regorafenib Tablets Revenue & Forecasts
5.2.1 By Application – Global Regorafenib Tablets Revenue, 2018-2023
5.2.2 By Application – Global Regorafenib Tablets Revenue, 2024-2029
5.2.3 By Application – Global Regorafenib Tablets Revenue Market Share, 2018-2029
5.3 By Application – Global Regorafenib Tablets Sales & Forecasts
5.3.1 By Application – Global Regorafenib Tablets Sales, 2018-2023
5.3.2 By Application – Global Regorafenib Tablets Sales, 2024-2029
5.3.3 By Application – Global Regorafenib Tablets Sales Market Share, 2018-2029
5.4 By Application – Global Regorafenib Tablets Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Regorafenib Tablets Market Size, 2022 & 2029
6.2 By Region – Global Regorafenib Tablets Revenue & Forecasts
6.2.1 By Region – Global Regorafenib Tablets Revenue, 2018-2023
6.2.2 By Region – Global Regorafenib Tablets Revenue, 2024-2029
6.2.3 By Region – Global Regorafenib Tablets Revenue Market Share, 2018-2029
6.3 By Region – Global Regorafenib Tablets Sales & Forecasts
6.3.1 By Region – Global Regorafenib Tablets Sales, 2018-2023
6.3.2 By Region – Global Regorafenib Tablets Sales, 2024-2029
6.3.3 By Region – Global Regorafenib Tablets Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Regorafenib Tablets Revenue, 2018-2029
6.4.2 By Country – North America Regorafenib Tablets Sales, 2018-2029
6.4.3 US Regorafenib Tablets Market Size, 2018-2029
6.4.4 Canada Regorafenib Tablets Market Size, 2018-2029
6.4.5 Mexico Regorafenib Tablets Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Regorafenib Tablets Revenue, 2018-2029
6.5.2 By Country – Europe Regorafenib Tablets Sales, 2018-2029
6.5.3 Germany Regorafenib Tablets Market Size, 2018-2029
6.5.4 France Regorafenib Tablets Market Size, 2018-2029
6.5.5 U.K. Regorafenib Tablets Market Size, 2018-2029
6.5.6 Italy Regorafenib Tablets Market Size, 2018-2029
6.5.7 Russia Regorafenib Tablets Market Size, 2018-2029
6.5.8 Nordic Countries Regorafenib Tablets Market Size, 2018-2029
6.5.9 Benelux Regorafenib Tablets Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Regorafenib Tablets Revenue, 2018-2029
6.6.2 By Region – Asia Regorafenib Tablets Sales, 2018-2029
6.6.3 China Regorafenib Tablets Market Size, 2018-2029
6.6.4 Japan Regorafenib Tablets Market Size, 2018-2029
6.6.5 South Korea Regorafenib Tablets Market Size, 2018-2029
6.6.6 Southeast Asia Regorafenib Tablets Market Size, 2018-2029
6.6.7 India Regorafenib Tablets Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Regorafenib Tablets Revenue, 2018-2029
6.7.2 By Country – South America Regorafenib Tablets Sales, 2018-2029
6.7.3 Brazil Regorafenib Tablets Market Size, 2018-2029
6.7.4 Argentina Regorafenib Tablets Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Regorafenib Tablets Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Regorafenib Tablets Sales, 2018-2029
6.8.3 Turkey Regorafenib Tablets Market Size, 2018-2029
6.8.4 Israel Regorafenib Tablets Market Size, 2018-2029
6.8.5 Saudi Arabia Regorafenib Tablets Market Size, 2018-2029
6.8.6 UAE Regorafenib Tablets Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Bayer
7.1.1 Bayer Company Summary
7.1.2 Bayer Business Overview
7.1.3 Bayer Regorafenib Tablets Major Product Offerings
7.1.4 Bayer Regorafenib Tablets Sales and Revenue in Global (2018-2023)
7.1.5 Bayer Key News & Latest Developments
7.2 Natco
7.2.1 Natco Company Summary
7.2.2 Natco Business Overview
7.2.3 Natco Regorafenib Tablets Major Product Offerings
7.2.4 Natco Regorafenib Tablets Sales and Revenue in Global (2018-2023)
7.2.5 Natco Key News & Latest Developments
7.3 Kimia Pharmaceutical
7.3.1 Kimia Pharmaceutical Company Summary
7.3.2 Kimia Pharmaceutical Business Overview
7.3.3 Kimia Pharmaceutical Regorafenib Tablets Major Product Offerings
7.3.4 Kimia Pharmaceutical Regorafenib Tablets Sales and Revenue in Global (2018-2023)
7.3.5 Kimia Pharmaceutical Key News & Latest Developments
7.4 Beacon Pharmaceuticals
7.4.1 Beacon Pharmaceuticals Company Summary
7.4.2 Beacon Pharmaceuticals Business Overview
7.4.3 Beacon Pharmaceuticals Regorafenib Tablets Major Product Offerings
7.4.4 Beacon Pharmaceuticals Regorafenib Tablets Sales and Revenue in Global (2018-2023)
7.4.5 Beacon Pharmaceuticals Key News & Latest Developments
7.5 Drug International
7.5.1 Drug International Company Summary
7.5.2 Drug International Business Overview
7.5.3 Drug International Regorafenib Tablets Major Product Offerings
7.5.4 Drug International Regorafenib Tablets Sales and Revenue in Global (2018-2023)
7.5.5 Drug International Key News & Latest Developments
8 Global Regorafenib Tablets Production Capacity, Analysis
8.1 Global Regorafenib Tablets Production Capacity, 2018-2029
8.2 Regorafenib Tablets Production Capacity of Key Manufacturers in Global Market
8.3 Global Regorafenib Tablets Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Regorafenib Tablets Supply Chain Analysis
10.1 Regorafenib Tablets Industry Value Chain
10.2 Regorafenib Tablets Upstream Market
10.3 Regorafenib Tablets Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Regorafenib Tablets Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Regorafenib Tablets in Global Market
Table 2. Top Regorafenib Tablets Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Regorafenib Tablets Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Regorafenib Tablets Revenue Share by Companies, 2018-2023
Table 5. Global Regorafenib Tablets Sales by Companies, (K Units), 2018-2023
Table 6. Global Regorafenib Tablets Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Regorafenib Tablets Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Regorafenib Tablets Product Type
Table 9. List of Global Tier 1 Regorafenib Tablets Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Regorafenib Tablets Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Regorafenib Tablets Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Regorafenib Tablets Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Regorafenib Tablets Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Regorafenib Tablets Sales (K Units), 2018-2023
Table 15. By Type - Global Regorafenib Tablets Sales (K Units), 2024-2029
Table 16. By Application – Global Regorafenib Tablets Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Regorafenib Tablets Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Regorafenib Tablets Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Regorafenib Tablets Sales (K Units), 2018-2023
Table 20. By Application - Global Regorafenib Tablets Sales (K Units), 2024-2029
Table 21. By Region – Global Regorafenib Tablets Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Regorafenib Tablets Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Regorafenib Tablets Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Regorafenib Tablets Sales (K Units), 2018-2023
Table 25. By Region - Global Regorafenib Tablets Sales (K Units), 2024-2029
Table 26. By Country - North America Regorafenib Tablets Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Regorafenib Tablets Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Regorafenib Tablets Sales, (K Units), 2018-2023
Table 29. By Country - North America Regorafenib Tablets Sales, (K Units), 2024-2029
Table 30. By Country - Europe Regorafenib Tablets Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Regorafenib Tablets Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Regorafenib Tablets Sales, (K Units), 2018-2023
Table 33. By Country - Europe Regorafenib Tablets Sales, (K Units), 2024-2029
Table 34. By Region - Asia Regorafenib Tablets Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Regorafenib Tablets Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Regorafenib Tablets Sales, (K Units), 2018-2023
Table 37. By Region - Asia Regorafenib Tablets Sales, (K Units), 2024-2029
Table 38. By Country - South America Regorafenib Tablets Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Regorafenib Tablets Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Regorafenib Tablets Sales, (K Units), 2018-2023
Table 41. By Country - South America Regorafenib Tablets Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Regorafenib Tablets Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Regorafenib Tablets Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Regorafenib Tablets Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Regorafenib Tablets Sales, (K Units), 2024-2029
Table 46. Bayer Company Summary
Table 47. Bayer Regorafenib Tablets Product Offerings
Table 48. Bayer Regorafenib Tablets Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Bayer Key News & Latest Developments
Table 50. Natco Company Summary
Table 51. Natco Regorafenib Tablets Product Offerings
Table 52. Natco Regorafenib Tablets Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Natco Key News & Latest Developments
Table 54. Kimia Pharmaceutical Company Summary
Table 55. Kimia Pharmaceutical Regorafenib Tablets Product Offerings
Table 56. Kimia Pharmaceutical Regorafenib Tablets Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Kimia Pharmaceutical Key News & Latest Developments
Table 58. Beacon Pharmaceuticals Company Summary
Table 59. Beacon Pharmaceuticals Regorafenib Tablets Product Offerings
Table 60. Beacon Pharmaceuticals Regorafenib Tablets Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Beacon Pharmaceuticals Key News & Latest Developments
Table 62. Drug International Company Summary
Table 63. Drug International Regorafenib Tablets Product Offerings
Table 64. Drug International Regorafenib Tablets Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Drug International Key News & Latest Developments
Table 66. Regorafenib Tablets Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 67. Global Regorafenib Tablets Capacity Market Share of Key Manufacturers, 2021-2023
Table 68. Global Regorafenib Tablets Production by Region, 2018-2023 (K Units)
Table 69. Global Regorafenib Tablets Production by Region, 2024-2029 (K Units)
Table 70. Regorafenib Tablets Market Opportunities & Trends in Global Market
Table 71. Regorafenib Tablets Market Drivers in Global Market
Table 72. Regorafenib Tablets Market Restraints in Global Market
Table 73. Regorafenib Tablets Raw Materials
Table 74. Regorafenib Tablets Raw Materials Suppliers in Global Market
Table 75. Typical Regorafenib Tablets Downstream
Table 76. Regorafenib Tablets Downstream Clients in Global Market
Table 77. Regorafenib Tablets Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Regorafenib Tablets Segment by Type in 2022
Figure 2. Regorafenib Tablets Segment by Application in 2022
Figure 3. Global Regorafenib Tablets Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Regorafenib Tablets Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Regorafenib Tablets Revenue, 2018-2029 (US$, Mn)
Figure 7. Regorafenib Tablets Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Regorafenib Tablets Revenue in 2022
Figure 9. By Type - Global Regorafenib Tablets Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Regorafenib Tablets Revenue Market Share, 2018-2029
Figure 11. By Type - Global Regorafenib Tablets Sales Market Share, 2018-2029
Figure 12. By Type - Global Regorafenib Tablets Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Regorafenib Tablets Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Regorafenib Tablets Revenue Market Share, 2018-2029
Figure 15. By Application - Global Regorafenib Tablets Sales Market Share, 2018-2029
Figure 16. By Application - Global Regorafenib Tablets Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Regorafenib Tablets Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Regorafenib Tablets Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Regorafenib Tablets Revenue Market Share, 2018-2029
Figure 20. By Region - Global Regorafenib Tablets Sales Market Share, 2018-2029
Figure 21. By Country - North America Regorafenib Tablets Revenue Market Share, 2018-2029
Figure 22. By Country - North America Regorafenib Tablets Sales Market Share, 2018-2029
Figure 23. US Regorafenib Tablets Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Regorafenib Tablets Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Regorafenib Tablets Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Regorafenib Tablets Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Regorafenib Tablets Sales Market Share, 2018-2029
Figure 28. Germany Regorafenib Tablets Revenue, (US$, Mn), 2018-2029
Figure 29. France Regorafenib Tablets Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Regorafenib Tablets Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Regorafenib Tablets Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Regorafenib Tablets Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Regorafenib Tablets Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Regorafenib Tablets Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Regorafenib Tablets Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Regorafenib Tablets Sales Market Share, 2018-2029
Figure 37. China Regorafenib Tablets Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Regorafenib Tablets Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Regorafenib Tablets Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Regorafenib Tablets Revenue, (US$, Mn), 2018-2029
Figure 41. India Regorafenib Tablets Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Regorafenib Tablets Revenue Market Share, 2018-2029
Figure 43. By Country - South America Regorafenib Tablets Sales Market Share, 2018-2029
Figure 44. Brazil Regorafenib Tablets Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Regorafenib Tablets Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Regorafenib Tablets Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Regorafenib Tablets Sales Market Share, 2018-2029
Figure 48. Turkey Regorafenib Tablets Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Regorafenib Tablets Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Regorafenib Tablets Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Regorafenib Tablets Revenue, (US$, Mn), 2018-2029
Figure 52. Global Regorafenib Tablets Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Regorafenib Tablets by Region, 2022 VS 2029
Figure 54. Regorafenib Tablets Industry Value Chain
Figure 55. Marketing Channels


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • メシル酸イマチニブ錠のグローバル市場展望 2023年-2029年：100 mg、400 mg
  • ポサコナゾール遅延放出錠のグローバル市場展望 2023年-2029年：先発医薬品、ジェネリック医薬品
  • 亜鉛錠剤のグローバル市場展望 2023年-2029年：処方箋、市販薬
  • グルクロラクトン錠剤のグローバル市場展望 2023年-2029年：50mg、10mg
  • デキストロメトルファン臭化水素酸塩錠のグローバル市場展望 2023年-2029年：徐放錠、分散錠
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(MMG23DC14455 )"レゴラフェニブ錠のグローバル市場展望 2023年-2029年：錠剤、分散錠、徐放錠" (英文：Regorafenib Tablets Market, Global Outlook and Forecast 2023-2029)はMarket Monitor Global社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。